Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer.

2-marker model: accuracy 86.7%, sensitivity 90.0%, specificity 83.1%.

J Clin Invest 2020;130(12):6278-6289. utMeMA.PubMed 32817589